Simvastatin loaded chitosan guided bone regeneration membranes stimulate bone healing
- 8 April 2021
- journal article
- research article
- Published by Wiley in Journal of Periodontal Research
- Vol. 56 (5) , 877-884
Abstract
Background and Objective: Electrospun chitosan membranes (ESCM) modified with short‐chain fatty acids have the ability to control the release of simvastatin (SMV), an anti‐cholesterol drug with osteogenic potential, for guided bone regeneration (GBR) applications. This study evaluated in vivo osteogenic effects of rapid short release of SMV (4 weeks) vs long sustained release (8 weeks) from acetic anhydride (AA)—and hexanoic anhydride (HA)‐modified ESCMs, respectively.Methods: AA ESCMs loaded with 10 or 50 µg SMV and HA ESCMs loaded with 50 µg SMV were evaluated for biocompatibility and bone formation at 4 and 8 weeks, in 5 mm critical size rat calvarial defects, using histological evaluation and micro‐CT analysis.Results: No severe inflammatory response was noticed around the ESCMs. Less hydrophobic AA membranes showed signs of resorption by week 4 and were almost completely resorbed by week 8 whereas the more hydrophobic HA membranes resorbed slowly, remaining intact over 8 weeks. In micro‐CT analysis, 10 µg SMV‐loaded AA membranes did not show significant bone formation as compared to non‐loaded AA membranes at either evaluation time points. 50 µg SMV‐loaded AA membranes stimulated significantly more bone formation than non‐loaded AA membranes by week 4 (%bone = 31.0 ± 5.9% (AA50) vs 18.5 ± 13.7% (AA0)) but showed no difference at week 8. HA membranes with 50 µg SMV showed significantly more bone formation as compared to corresponding non‐loaded membranes by week 8 (%bone = 61.7 ± 8.9% (HA50) vs 33.9 ± 29.7% (HA0)), though such an effect was not significant at week 4.Conclusion: These results indicate that modified ESCMs may be used to control the release of SMV and promote bone healing in GBR applications.Keywords
This publication has 30 references indexed in Scilit:
- Combination of a Bioceramic Scaffold and Simvastatin Nanoparticles as a Synthetic Alternative to Autologous Bone GraftingInternational Journal of Molecular Sciences, 2018
- Mechanically stable surface-hydrophobilized chitosan nanofibrous barrier membranes for guided bone regenerationBiomedical Materials, 2017
- Guided bone regeneration is promoted by the molecular events in the membrane compartmentBiomaterials, 2016
- Three-Dimensional Porous Gelapin–Simvastatin Scaffolds Promoted Bone Defect Healing in RabbitsCalcified Tissue International, 2015
- The stabilization of electrospun chitosan nanofibers by reversible acylationCellulose, 2014
- The effect of simvastatin-loaded polymeric microspheres in a critical size bone defect in the rabbit calvariaInternational Journal of Pharmaceutics, 2014
- Chitosan as a barrier membrane material in periodontal tissue regenerationJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2012
- Stability Improvement of Electrospun Chitosan Nanofibrous Membranes in Neutral or Weak Basic Aqueous SolutionsBiomacromolecules, 2006
- Effect of HMG-CoA Reductase Inhibitors (Statins) on Bone Mineral DensityJournal of Clinical Densitometry, 2002
- HMG-CoA Reductase Inhibitors and the Risk of Hip Fractures in Elderly PatientsJAMA, 2000